Connor, Clark & Lunn Investment Management Ltd.

Position in NVS — Novartis AG

CIK 1596800 VANCOUVER, A1

Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$116,056,174

+$38,850,214 QoQ

Shares Held

740,532

+46.5% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#32

of 1,603 holders

Holding Since

Mar 2020

20 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. NVS ranks #4 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	173,392	$207,971,583
2	ABBV	AbbVie Inc.	751,485	$189,103,685
3	GSK	GSK plc	2,767,591	$145,077,119
4	NVS	Novartis AG This page	740,532	$116,056,174
5	SNY	Sanofi	1,835,859	$78,317,744
6	JNJ	Johnson & Johnson	307,423	$78,076,219
7	GILD	Gilead Sciences, Inc.	46,429	$5,865,839
8	MRK	Merck & Co., Inc.	38,087	$4,894,179

All Filings in NVS

Export CSV

20 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$116,056,174	740,532	+46.5%	Shares	Sole	2026-08-13
2026-03-31	$77,205,960	505,440	-22.4%	Shares	Sole	2026-05-11
2025-12-31	$89,773,223	651,144	+1445.9%	Shares	Sole	2026-02-10
2025-09-30	$5,401,725	42,122	+48.5%	Shares	Sole	2025-11-13
2025-06-30	$3,432,327	28,364	-69.5%	Shares	Sole	2025-08-07
2025-03-31	$10,367,194	92,996	+1002.8%	Shares	Sole	2025-05-12
2024-12-31	$820,615	8,433	-95.6%	Shares	Sole	2025-02-10
2024-09-30	$22,005,281	191,317	+145.1%	Shares	Sole	2024-11-08
2024-06-30	$8,309,948	78,057	+612.1%	Shares	Sole	2024-08-09
2024-03-31	$1,060,354	10,962	-85.8%	Shares	Sole	2024-05-09
2023-12-31	$7,796,196	77,213	-74.7%	Shares	Sole	2024-02-09
2023-09-30	$31,082,579	305,150	-35.4%	Shares	Sole	2023-11-13
2023-06-30	$47,671,296	472,414	+55.8%	Shares	Sole	2023-08-10
2023-03-31	$27,890,536	303,158	-51.1%	Shares	Sole	2023-05-10
2022-12-31	$56,240,231	619,932	+872.0%	Shares	Sole	2023-02-10
2022-09-30	$4,847,765	63,778	+31.7%	Shares	Sole	2022-11-10
2022-06-30	$4,094,548	48,439	+6.3%	Shares	Sole	2022-08-05
2021-12-31	$3,985,570	45,565	+1592.0%	Shares	Sole	2022-02-10
2020-06-30	$235,206	2,693	+7.7%	Shares	Sole	2020-08-13
2020-03-31	$206,125	2,500	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.